{'fraction_non_alphanumeric': 0.03489096573208723, 'fraction_numerical': 0.02679127725856698, 'mean_word_length': 5.502024291497976, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Hyperoxia induces Egr‐1 expression through activation of extracellular signal‐regulated kinase 1/2 pathway

Early growth response gene (Egr‐1) is a stress response gene activated by various forms of stress and growth factor signaling. We report that supraphysiologic concentrations of O2 (hyperoxia) induced Egr‐1 mRNA and protein expression in cultured alveolar epithelial cells, as well as in mouse lung in vivo. The contribution of the mitogen‐activated protein kinase kinase (MEK)/extracellular signal‐regulated kinase (ERK), p38 MAPK and PI3‐kinase pathways to the activation of Egr‐1 in response to hyperoxia was examined. Exposure to hyperoxia resulted in a rapid phosphorylation of ERK 1/2 kinases in mouse alveolar epithelial cells LA4. MEK inhibitor PD98059, but not inhibitors of p38 MAPK or PI3‐kinase pathway, prevented Egr‐1 induction by hyperoxia. The signaling cascade preceding Egr‐1 activation was traced to epidermal growth factor receptor (EGFR) signaling. Hyperoxia is used as supplemental therapy in some diseases and typically results in elevated levels of reactive oxygen intermediates (ROI) in many lung cell types, the organ that receives highest O2 exposure. Our results support a pathway for the hyperoxia response that involves EGF receptor, MEK/ERK pathway, and other unknown signaling components leading to Egr‐1 induction. This forms a foundation for analysis of detailed mechanisms underlying Egr‐1 activation during hyperoxia and understanding its consequences for regulating cell response to oxygen toxicity. J. Cell. Physiol. 196: 326–333, 2003. © 2003 Wiley‐Liss, Inc.